Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through p53-Mediated Apoptosis

被引:20
作者
Kim, Aeyung [1 ]
Lee, Seo-Young [2 ]
Seo, Chang-Seob [2 ]
Chung, Sun-Ku [1 ]
机构
[1] Korea Inst Oriental Med, Clin Med Div, Daejeon 34054, South Korea
[2] Korea Inst Oriental Med, Herbal Med Res Div, Daejeon 34054, South Korea
关键词
induced pluripotent stem cell; teratoma; magnolia cortex; apoptosis; p53; REGENERATIVE MEDICINE; DEATH; TUMORIGENICITY; GAMMA-H2AX;
D O I
10.3390/nu12030721
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Induced pluripotent stem cells (iPSCs) have similar properties to embryonic stem cells in terms of indefinite self-renewal and differentiation capacity. After in vitro differentiation of iPSCs, undifferentiated iPSCs (USCs) may exist in cell therapy material and can form teratomas after in vivo transplantation. Selective elimination of residual USCs is, therefore, very important. Prunellae Spica (PS) is a traditional medicinal plant that has been shown to exert anti-cancer, antioxidant, and anti-inflammatory activities; however, its effects on iPSCs have not been previously characterized. In this study, we find that ethanol extract of PS (EPS) effectively induces apoptotic cell death of USCs through G2/M cell cycle arrest, generation of intracellular reactive oxygen species, alteration of mitochondrial membrane potentials, and caspase activation of USCs. In addition, EPS increases p53 accumulation and expression of its downstream targets. In p53 knockout (KO) iPSCs, the EPS did not induce apoptosis, indicating that EPS-mediated apoptosis of USCs was p53-dependent. In addition, EPS was not genotoxic towards iPSCs-derived differentiated cells. EPS treatment before injection efficiently prevented in ovo teratoma formation of p53 wild-type (WT) iPSCs but not p53KO iPSCs. Collectively, these results indicate that EPS has potent anti-teratoma activity and no genotoxicity to differentiated cells. It can, therefore, be used in the development of safe and efficient iPSC-based cell therapies.
引用
收藏
页数:21
相关论文
共 43 条
[1]   Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson's disease [J].
Acquarone, Mariana ;
de Melo, Thiago M. ;
Meireles, Fernanda ;
Brito-Moreiras, Jordano ;
Oliveira, Gabriel ;
Ferreira, Sergio T. ;
Castro, Newton G. ;
Tovar-Moil, Fernanda ;
Houzel, Jean-Christophe ;
Rehen, Stevens K. .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9 :1-12
[2]   Dinaciclib potently suppresses MCL-1 and selectively induces the cell death in human iPS cells without affecting the viability of cardiac tissue [J].
Alsayegh, Khaled ;
Matsuura, Katsuhisa ;
Sekine, Hidekazu ;
Shimizu, Tatsuya .
SCIENTIFIC REPORTS, 2017, 7
[3]  
Amaral JD, 2010, DISCOV MED, V9, P145
[4]   Selective Elimination of Human Pluripotent Stem Cells by an Oleate Synthesis Inhibitor Discovered in a High-Throughput Screen [J].
Ben-David, Uri ;
Gan, Qing-Fen ;
Golan-Lev, Tamar ;
Arora, Payal ;
Yanuka, Ofra ;
Oren, Yifat S. ;
Leikin-Frenkel, Alicia ;
Graf, Martin ;
Garippa, Ralph ;
Boehringer, Markus ;
Gromo, Gianni ;
Benvenisty, Nissim .
CELL STEM CELL, 2013, 12 (02) :167-179
[5]   The tumorigenicity of human embryonic and induced pluripotent stem cells [J].
Ben-David, Uri ;
Benvenisty, Nissim .
NATURE REVIEWS CANCER, 2011, 11 (04) :268-277
[6]   Botanical medicine and cancer: a review of the safety and efficacy [J].
Boon, H ;
Wong, J .
EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (12) :2485-2501
[7]   Activation of DNA damage response signaling in mouse embryonic stem cells [J].
Chuykin, Ilya A. ;
Lianguzova, Maria S. ;
Pospelova, Tatiana V. ;
Pospelov, Valery A. .
CELL CYCLE, 2008, 7 (18) :2922-2928
[8]  
Fang Luo, 2010, Zhongguo Zhong Yao Za Zhi, V35, P616
[9]   Spica Prunellae extract suppresses the growth of human colon carcinoma cells by targeting multiple oncogenes via activating miR-34a [J].
Fang, Yi ;
Zhang, Ling ;
Feng, Jianyu ;
Lin, Wei ;
Cai, Qiaoyan ;
Peng, Jun .
ONCOLOGY REPORTS, 2017, 38 (03) :1895-1901
[10]   Herbal Medicine Today: Clinical and Research Issues [J].
Firenzuoli, Fabio ;
Gori, Luigi .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2007, 4 :37-40